Sir John Robert Vane was a British pharmacologist who was instrumental in the understanding of how aspirin produces pain-relief and anti-inflammatory effects and his work led to new treatments for heart and blood vessel disease and introduction of ACE inhibitors. He was awarded the Nobel Prize in Physiology or Medicine in 1982 along with Sune Bergström and Bengt Samuelsson for "their discoveries concerning prostaglandins and related biologically active substances".
Clinical pharmacology is "that discipline that teaches, does research, frames policy, gives information and advice about the actions and proper uses of medicines in humans and implements that knowledge in clinical practice". Clinical pharmacology is inherently a translational discipline underpinned by the basic science of pharmacology, engaged in the experimental and observational study of the disposition and effects of drugs in humans, and committed to the translation of science into evidence-based therapeutics. It has a broad scope, from the discovery of new target molecules to the effects of drug usage in whole populations. The main aim of clinical pharmacology is to generate data for optimum use of drugs and the practice of 'evidence-based medicine'.
The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate Better Medicines through Global Education and Research around the world.
The Commission on Human Medicines (CHM) is a committee of the UK's Medicines and Healthcare products Regulatory Agency. It was formed in October 2005, and assumed the responsibilities of the Medicines Commission and the Committee on Safety of Medicines. Membership in this various and extensive body is listed on a governmental website.
Marthe Louise Vogt was a German scientist recognized as one of the leading neuroscientists of the twentieth century. She is mainly remembered for her important contributions to the understanding of the role of neurotransmitters in the brain, especially epinephrine.
David Anthony Brown, (1936–2023) was emeritus Professor of Pharmacology at University College London, having joined the department in April 1987 and served as Head of Department from October 1987 to April 2002.
Ullrich Georg Trendelenburg was a German pharmacologist.
Donald Robert James Singer was a British clinical pharmacologist who was the president of the Fellowship of Postgraduate Medicine.
Sir Michael David Rawlins was a British clinical pharmacologist and emeritus professor at the University of Newcastle upon Tyne. During his medical career he chaired several executive agencies including the Committee on Safety of Medicines from 1993 to 1998, followed by the National Institute for Health and Care Excellence (NICE) for 14 years from its formation in 1999 and then the Medicines and Healthcare products Regulatory Agency (MHRA) for six years from 2014. From 2012 to 2014 he was president of the Royal Society of Medicine.
Joshua Harold Burn FRS was an English pharmacologist and professor of pharmacology at Oxford University.
Professor Sir Munir Pirmohamed is a British clinical pharmacologist and geneticist. Since 2007 he has been the NHS Chair of Pharmacogenetics at the University of Liverpool.
Sir Derrick Melville Dunlop was a Scottish physician and pharmacologist in British medical administration and policy-making in the late 20th century. Sir Derrick established the Dunlop Committee which investigates the side-effects of new drugs in the UK.
David John Webb is a British physician, scientist and clinical pharmacologist, who currently holds the Christison Chair of Therapeutics and Clinical Pharmacology at the University of Edinburgh.
Jeffrey Kenneth Aronson is a British physician and clinical pharmacologist, currently working in the Centre for Evidence Based Medicine in Oxford.
Sir Alasdair Muir Breckenridge, was a Scottish pharmacologist.
Fiona Hamilton Marshall is a British pharmacologist, biotech-founder and President of Biomedical Research at Novartis. She founded and previously served as Chief Scientific Officer at Heptares Therapeutics, which was acquired by the Japanese biopharmaceutical company Sosei, where she served as Vice President. She was elected Fellow of the Academy of Medical Sciences in 2016 and the Royal Society in 2021.
Malcolm Rowland FBPhS is Emeritus Professor of Pharmacy, University of Manchester, and adjunct professor, University of California San Francisco. His research in pharmacology, has been particularly in physiologically based pharmacokinetics. He has written several textbooks on the subject.
Jean Gray is a Canadian academic and retired physician, who is professor emeritus of medical education, medicine and pharmacology at Dalhousie University. She has served as president of the Canadian and American Society of Clinical Pharmacology. She was invested as a Member of the Order of Canada in 2005, and has been a Fellow of the Royal College of Physicians since 2007. She was inducted into the Canadian Medical Hall of Fame in 2020.
Arthur Henry Weston is emeritus professor at the University of Manchester, where he was previously Leech Professor of Pharmacology from 1989-2011.
Nuala Ann Helsby is a New Zealand academic, and is a full professor of molecular medicine and pathology at the University of Auckland, specialising in transport of anticancer pharmaceuticals and drug treatments for autoimmune conditions.
